
1. plos one. 2014 nov 13;9(11):e112571. doi: 10.1371/journal.pone.0112571.
ecollection 2014.

plasmodium falciparum transfected ultra bright nanoluc luciferase offers
high sensitivity detection screening growth cellular trafficking
inhibitors.

azevedo mf(1), nie cq(1), elsworth b(2), charnaud sc(2), sanders pr(1), crabb
bs(3), gilson pr(2).

author information: 
(1)macfarlane burnet institute medical research public health, melbourne, 
victoria, australia.
(2)macfarlane burnet institute medical research public health, melbourne, 
victoria, australia; monash university, melbourne, australia.
(3)macfarlane burnet institute medical research public health, melbourne, 
victoria, australia; monash university, melbourne, australia; university of
melbourne, melbourne, australia.

drug discovery key part malaria control eradication strategies, and
could benefit sensitive affordable assays quantify parasite growth
and help identify targets potential anti-malarial compounds.
bioluminescence, achieved expression exogenous luciferases, a
powerful tool applied studies several aspects parasite
biology high throughput growth assays. expressed new reporter
nanoluc (nluc) luciferase plasmodium falciparum showed least 100 
times brighter commonly used firefly luciferase. nluc brightness was
explored means achieve growth assay higher sensitivity lower
cost. addition attempted develop screening assays may help
interrogate libraries inhibitory compounds mechanism action. to
this end parasites engineered express nluc cytoplasm, the
parasitophorous vacuole surrounds intraerythrocytic parasite exported
to red blood cell cytosol. proof-of-concept, parasites used 
develop functional screening assays quantifying effects brefeldin a,
an inhibitor protein secretion, furosemide, inhibitor new permeation
pathways used parasites acquire plasma nutrients.

doi: 10.1371/journal.pone.0112571 
pmcid: pmc4231029
pmid: 25392998  [indexed medline]

